Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares of the company, with an aggregate market value of $45,376.21, on 08/29/2024. The shares were originally acquired on the same date through an option granted on 07/23/2018. Over the past three months, a total of 15,000 shares have been sold by the officer, generating gross proceeds of $118,334.40. The upcoming sale is part of a planned transaction set on 03/01/2024.

Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares of the company, with an aggregate market value of $45,376.21, on 08/29/2024. The shares were originally acquired on the same date through an option granted on 07/23/2018. Over the past three months, a total of 15,000 shares have been sold by the officer, generating gross proceeds of $118,334.40. The upcoming sale is part of a planned transaction set on 03/01/2024.